
8 companies · 8 sourced backers · 39 milestones on record
Longevity and age-reversal research aims to extend healthy life by understanding aging and developing ways to prevent or treat age-related disease. Companies are exploring medicines that restore aged cells and tissues, alongside using genomic and other health information to identify and manage risks earlier.
Where the 8 companies stand today, from their profiles and 10-year milestones. Tap a phase to see who is there.
Publicly listed: 1 company (owned by public shareholders).
Full success would mean turning cellular rejuvenation into approved medicines that can restore cell health and treat or reverse age-related disease in patien…
Lab
To develop a broad pipeline of therapies that target the biology of aging itself, extending the number of years people live in good health.
Lab · publicly listed
Full success would mean turning fundamental discoveries about why we age into approved therapies that prevent or treat age-related diseases — a long-horizon …
Lab
Full success would mean a new class of fast-acting, durable psychiatric medicines that treat depression and related disorders far better than today's antidep…
Lab
To use genomic and other health information to support preventive, personalised care.
Some users
Full success would mean a platform that reverses cellular aging to restore function in diseased tissues — beginning with vision restoration — moving from its…
Lab
Full success would mean medicines that restore youthful function to aged cells and tissues, adding healthy years to human life — a goal NewLimit is pursuing …
Lab · backed by Founders Fund
The company's stated mission is to extend healthy human lifespan by 10 years by bringing therapies that reverse age-related disease through clinical trials t…
Lab
Keep following breakthroughs like these. Every Monday, get up to 5 major breakthroughs and launches explained in plain English.
Free. No account needed. One email a week. Unsubscribe anytime.